Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) signed a letter of intent to acquire Jilin Changyuan Pharmaceutical Co., Ltd. from Jiangxi Jixin Biotechnology Co., Ltd. for CNY 160 million on ...
"The Bioengineering program at Santa Clara University provided me with wonderful opportunities to explore and develop my interests in the fields of biotechnology and biomedical engineering. As an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results